Endogenous Shear‐Responsive Chemiluminescence Theranostics for Self‐Illuminating Thrombosis Imaging and Piezo‐Photodynamic Therapy
Advanced Healthcare Materials · 2026-06 · 15 (24)
DOI: 10.1002/adhm.71238 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 08.05.2026. Verfasst von Wenxiong Cao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Engineering, College of Medicine, Key Laboratory of Advanced Technologies of Materials, Ministry of Education, Southwest Jiao…. Hauptthemen laut MEDLINE: Photochemotherapy, Thrombosis, Theranostic Nanomedicine. Die Arbeit nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Thrombotic diseases represent a major global health challenge, yet current theranostic systems suffer from bleeding risks, rapid agent clearance, and external irradiation reliance. To tackle these issues, we developed a shear stress‐responsive platform integrating endogenous piezoelectric thrombolysis and on‐site chemiluminescence imaging. Specifically, calcium‐/zirconium‐doped barium titanate (BCTZ) nanorods (NRs) modified with chlorin e6 (Ce6), luminol, and Arg‐Gly‐Asp (RGD) peptides, yielding BCTZ@CeLu‐R NRs. A strong correlation is demonstrated between piezoelectric potentials and the degree of stenosis, providing rational mechanical signals for stenosis‐adaptive thrombus imaging and thrombolysis. The shear force‐triggered piezocatalysis operates according to energy band theory, as evidenced by thoroughly monitoring degradation rates of various dyes in media with different pH values. Piezocatalysis of NRs primarily generates ·OH and ·O 2 − to oxidize luminol and generate chemiluminescence, which, in turn, activates Ce6 to emit fluorescence for imaging and producing 1 O 2 for photodynamic therapy (PDT), creating a piezocatalysis‐chemiluminescence‐energy transfer cascade. In a rat model of carotid artery thrombosis, RGD‐targeted NRs achieve four‐fold higher luminescence for deep‐tissue imaging without external excitation, and combined piezocatalysis, PDT, and RGD‐mediated targeting realize 97.7% thrombolysis efficiency. This work pioneers an innovative theranostic approach driven by endogenous shear force, enabling clot site‐specific and stenosis degree‐adaptive thrombosis imaging and thrombus dissolution.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomedical Engineering, College of Medicine, Key Laboratory of Advanced Technologies of Materials, Ministry of Education, Southwest Jiaotong University, Chengdu, P. R. China.
- Key Laboratory of Tropical Biological Resources of Ministry of Education and Hainan Engineering Research Center for Drug Screening and Evaluation, School of Pharmaceutical Sciences, Hainan University, Haikou, P. R. Chin…
ORCID-Profile: Xiaohong Li
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Cao, W., Fang, Q., Ran, P., Zheng, H., Xie, S., Liu, Y., & Li, X. (2026). Endogenous Shear‐Responsive Chemiluminescence Theranostics for Self‐Illuminating Thrombosis Imaging and Piezo‐Photodynamic Therapy. Advanced Healthcare Materials, 15(24). https://doi.org/10.1002/adhm.71238
Vancouver
Cao W, Fang Q, Ran P, Zheng H, Xie S, Liu Y, et al. Endogenous Shear‐Responsive Chemiluminescence Theranostics for Self‐Illuminating Thrombosis Imaging and Piezo‐Photodynamic Therapy. Advanced Healthcare Materials. 2026;15(24). doi:10.1002/adhm.71238
BibTeX
@article{Cao2026,
author = {Cao, Wenxiong and Fang, Qibo and Ran, Pan and Zheng, Huan and Xie, Shuang and Liu, Yuan and Li, Xiaohong},
title = {Endogenous Shear‐Responsive Chemiluminescence Theranostics for Self‐Illuminating Thrombosis Imaging and Piezo‐Photodynamic Therapy},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {24},
doi = {10.1002/adhm.71238}
}
EUVIMED